Germany's Merck halts supply of cancer drug to Greek hospitals Reuters FRANKFURT (Reuters) - German pharmaceuticals firm Merck KGaA is no longer delivering cancer drug Erbitux to Greek hospitals, a spokesman said on Saturday, the latest sign of how an economic and budget crisis is hurting frontline public services. |
 |
| READ THE ORIGINAL POST AT www.reuters.com |
